Keira Bell: The High Court hands down a historic judgment to protect vulnerable children
from Transgender Trend:
In a landmark judgment that will have repercussions around the world the High Court today ruled that puberty blockers and cross-sex hormones are experimental treatments which cannot be given to children in most cases without application to the court.
We are delighted that the High Court has handed down judgment to protect children from experimental medical interventions with serious known and unknown risks and lifelong consequences.
The judgment concluded that it is highly unlikely that a child aged 13 or under would ever be Gillick competent to give consent to being treated with puberty blockers and very doubtful that children aged 14 and 15 could understand the long-term risks and consequences of treatment in such a way as to have sufficient understanding to give consent.
The court also ruled that it would be appropriate for clinicians to involve the court in any case where there may be any doubt as to whether the long-term interests of a 16 or 17 year-old would be served by the clinical interventions of blockers and hormones.
The judgment is vindication for Sue Evans who instigated the case and first raised concerns at the GIDS over fifteen years ago. It is testament to the courage of the claimants, Mrs A and Keira Bell who, through her public testimony, has changed history.
In her witness statement, Keira Bell said:
[…] On the basis of the landmark judgment handed down in court today, the government needs to take action to remove all transgender guidance and resources from schools and social services departments to safeguard children and prevent any further teaching of this ideology to children as ‘fact’. The Health Secretary must take steps to curb the influence of these lobby groups and eliminate ideology from medical theory and practice. Government departments, health bodies and schools must cancel their membership of the Stonewall Diversity Champions scheme.
Please right-click links to open in a new window.
Related Posts
Tags
Share This
